Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatrogon vs Genotropin in SGA or ISS Pediatric Patients
NCT07226089Phase 3Recruiting
- Sponsor
- Rabin Medical Center
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 3 trial of somatrogon in Idiopathic Short Stature (ISS), Small for gestational age (SGA), sponsored by Rabin Medical Center. Started Feb 2026; status: recruiting.
02
Drugs
somatrogon
03
Conditions
Idiopathic Short Stature (ISS)Small for gestational age (SGA)
Beyond the preview
Go deeper on NCT07226089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07226089.